Screener
GNOM vs IPAV
Global X Genomics & Biotechnology ETF vs Global X Infrastructure Development ex-U.S. ETF
Key differences
- GNOM costs 0.05% less per year.
- GNOM is significantly larger than IPAV — larger funds tend to be more liquid and less likely to close.
- GNOM covers north america markets; IPAV covers global.
- GNOM has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| GNOM | IPAV | |
|---|---|---|
| Annual cost (TER) | 0.50% | 0.55% |
| Fund size (AUM) | $51M | $5M |
| Since | 2019 | 2024 |
| Dividend yield | 1.38% | 1.14% |
| Asset class | equity | equity |
| Region | north america | global |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +57.9% | +31.2% |
| CAGR 3Y | -1.5% | N/A |
| CAGR 5Y | -10.0% | N/A |
| Sharpe 3Y | -0.02 | N/A |
| Volatility 1Y | 26.22% | 17.09% |
| Max drawdown | -75.00% | -14.59% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to GNOM and IPAV
Explore further